AMSilk | Biogenius Materials Revenue

Biotechnology Research • Neuried, Bavaria, Germany • 51-100 Employees

AMSilk | Biogenius Materials revenue & valuation

Annual revenue	$7,000,000
Revenue per employee	$88,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$22,400,000
Total funding	$62,500,000

Key Contacts at AMSilk | Biogenius Materials

Ulrich Scherbel

Ceo

Tobias Kraxenberger

Head Of Production Technology

Company overview

Headquarters	Anna-Sigmund Straße 1-3, Neuried, Bavaria 82061, DE
Phone number	+498957953930
Website	amsilk.com
NAICS	541714
SIC	229
Keywords	Medical Devices, Biotech, Consumer Goods, Biopolymers, Textile Fibers, Biotech Materials, Zero-Waste Society
Founded	2008
Employees	51-100
Socials

AMSilk | Biogenius Materials Email Formats

AMSilk | Biogenius Materials uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@amsilk.com), used 50.9% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@amsilk.com	50.9%
{first initial}.{last name}	j.doe@amsilk.com	49.1%

About AMSilk | Biogenius Materials

AMSilk's Biogenius Materials made from silk proteins are setting new standards in material innovation. Using cutting-edge science and the most advanced technologies like DNA edition, protein engineering and precision fermentation, we transform biogenic materials inspired by nature into groundbreaking Biongenius Materials. At AMSilk, we turn man-made proteins into formulations, including fibers and yarns, hydrogels and silk powder. The high-performance qualities of our material enable a wide range of applications in the textile, homecare, biomedical, and automobile industries and bring breakthrough benefits for products and customers.

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry

Manager

Head

Employees by Department

AMSilk | Biogenius Materials has 41 employees across 11 departments.

Departments

Number of employees

Funding Data

Explore AMSilk | Biogenius Materials's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-05-04	6	$27,400,000
2025-10-09	1	$35,100,000

Funding Insights

$62,500,000

Total funding amount

$35,100,000

Most recent funding amount

Number of funding rounds

AMSilk | Biogenius Materials Tech Stack

Discover the technologies and tools that power AMSilk | Biogenius Materials's digital infrastructure, from frameworks to analytics platforms.

Apache HTTP Server

Web servers

Cookiebot

Cookie compliance

Contact Form 7

Form builders

Instant.Page

JavaScript libraries

Open Graph

Miscellaneous

PHP

Programming languages

GSAP

JavaScript frameworks

Cookie Control

Cookie compliance

IONOS

Hosting

WordPress

Blogs

Altcha

Security

Matomo Analytics

Analytics

Frequently asked questions

AMSilk | Biogenius Materials is located in Neuried, Bavaria, DE.

You can reach AMSilk | Biogenius Materials at +498957953930.

AMSilk | Biogenius Materials generates an estimated annual revenue of $7,000,000. This revenue figure reflects the company's market position and business performance in its industry.

AMSilk | Biogenius Materials has an estimated valuation of $22,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

AMSilk | Biogenius Materials was founded in 2008, making it 18 years old. The company has established itself as a significant player in its industry over this time.

AMSilk | Biogenius Materials has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

AMSilk | Biogenius Materials has raised a total of $62,500,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at AMSilk | Biogenius Materials

Ulrich Scherbel

Ceo

Tobias Kraxenberger

Head Of Production Technology

4.8

40,000 users